10x Genomics (TXG) Price to Sales (2019 - 2026)

10x Genomics has disclosed Price to Sales across 8 years of filings, most recently posting 33.07 for Q2 2026.

• In Q2 2026, Price to Sales rose 296.82% year-over-year to 33.07; the TTM figure through Jun 2026 stood at 8.1 (up 262.11% YoY), while the FY2025 annual figure was 3.24, up 12.68% from the prior year.
• Price to Sales came in at 33.07 for Q2 2026 at 10x Genomics, up from 18.15 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 75.26 in Q1 2022 to a low of 6.94 in Q1 2025.
• Average Price to Sales over 5 years is 27.64, with a median of 25.87 recorded in 2022.
• Year-over-year, Price to Sales tumbled 80.81% in 2022 and soared 296.82% in 2026.
• Over 5 years, Price to Sales stood at 26.87 in 2022, then jumped by 34.82% to 36.22 in 2023, then slumped by 70.62% to 10.64 in 2024, then advanced by 17.87% to 12.54 in 2025, then soared by 163.65% to 33.07 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 33.07 in Q2 2026, 18.15 in Q1 2026, and 12.54 in Q4 2025.